Servier Nederland Podcast - Hematologie Trailer Bonus Aflevering 12 Seizoen 1

AML highlights EHA 2023 - Remco Molenaar

AML highlights EHA 2023 - Remco MolenaarAML highlights EHA 2023 - Remco Molenaar

00:00

00:00 18:57

Downloaden

Meer afleveringen

AML highlights EHA 2023 - Remco Molenaar
19 min

Servier Nederland Podcast - Hematologie Trailer Bonus Aflevering 12 Seizoen 1

AML highlights EHA 2023 - Remco Molenaar

6 Juli 2023 Servier Nederland Volledig transcript Bekijk de website

In deze podcast bespreekt Remco Molenaar de volgens hem meest relevante abstracts en presentaties van het EHA 2023 over de behandeling van AML.

Updated survival, blood count recovery and safety results from the agile study in patients with acute myeloid leukemia treated with ivosidenib + azacitidine compared to placebo + azacitidine eha2023 - presentation detail (ehaweb.org)
s122 mutant idh1 hijacks differentiation programs in myeloid progenitor cells to impair granulocytic differentiation.eha2023 - presentation detail (ehaweb.org)
(morpho): a randomized trial of the flt3 inhibitor gilteritinib as posttransplant maintenance for flt3-itd AML
Activity, tolerability, and resistance profile of the menin inhibitor ziftomenib in adults with relapsed/refractory npm1-mutated AML
Differential target profiles and efficacy of adclec.syn1 and cd33-cars in humanized AML models

Hoofdstukken